Emergence of vancomycin-intermediate Staphylococcus aureus and S. sciuri, Greece.
Tsakris
Athanassios
A
Papadimitriou
Ekaterini
E
Douboyas
John
J
Stylianopoulou
Fotini
F
Manolis
Evangelos
E
D000328:Adult; D000900:Anti-Bacterial Agents / Q000494:pharmacology* / Q000627:therapeutic use; D024901:Drug Resistance, Multiple, Bacterial; D005839:Gentamicins / Q000494:pharmacology / Q000627:therapeutic use; D006115:Greece; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000382:microbiology*; D013210:Staphylococcus / Q000187:drug effects* / Q000235:genetics / Q000302:isolation & purification* / Q000502:physiology; D017334:Teicoplanin / Q000494:pharmacology* / Q000627:therapeutic use; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000494:pharmacology / Q000627:therapeutic use; D014640:Vancomycin / Q000494:pharmacology* / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D005839:Gentamicins; D017334:Teicoplanin; D014640:Vancomycin; D015662:Trimethoprim, Sulfamethoxazole Drug Combination